Our High DHA Fish Oil is unique in its purity and concentration. It provides at least 75% active ingredients, leaving less room for nonessential compounds found in other fish oils. Numerous health organizations around the world recommend an adequate daily dose of omega-3 fatty acids. The advantages of these acids continue to emerge including potential benefits to cardiovascular, neurological, vision and joint health. There is some evidence they can even boost mental health.
- Technical Specs
High DHA Fish Oil is indicated for those individuals that want a higher ratio of DHA to EPA in small, pure, and potent softgels for neurological, vision, maternity, or general health.
Ingredients / Formula
Serving Size 2 fish gelatin softgels (size 11 oblong) contain:
- Omega-3 Supercritical CO2
- Triglyceride Concentrate 1,250 mg
- Providing: DHA (Docosahexaenoic Acid) 775 mg and EPA (Eicosapentaenoic Acid) 200 mg
Adults take 2 softgels daily with a meal, or as directed by your health care professional.
No adverse effects have been reported.
Store in a cool, dry place, away from direct light. Keep out of reach of children.
- Extended Information
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Dyerberg J. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids. 2010 Sep;83(3):137-41.
Neubronner J. Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. Eur J Clin Nutr. 2011 Feb;65(2):247-54.
Yzebe D, Lievre M. Fish oils in the care of coronary heart disease patients: a meta- analysis of randomized controlled trials. Fundam Clin Pharmacol 2004;18:581-92.
Micallef M.A., Munro I.A., Garg M. L. An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. European Journal of Clinical Nutrition 2009 63,1154-1156.
Cho E, Hung S, Willet W, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001;73:209-18.
Malcolm CA, McCulloch DL, Montgomery C, et al. Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch Dis Child Fetal Neonatal Ed 2003;88:F383-90.
Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003;60:940-6.